Difficulty: Medium
Average Score: 65%
Practice
Prenatal screening is recommended for all pregnant women to detect neural tube defect. If a neural tube defect is present, one of the following is often elevated
Correct answer
B
Rationale
In prenatal screening for neural tube defects, elevated alpha-fetoprotein (AFP) levels are often detected. AFP is produced by the fetal liver and yolk sac, and elevated levels can indicate a neural tube defect like spina bifida or anencephaly. This screening is crucial for early detection and intervention to prevent potential complications for the fetus.
Option A, human chorionic gonadotropin (hCG), is a hormone produced during pregnancy but is not specifically associated with neural tube defects. Estriol (Option C) is a hormone produced by the placenta and fetal liver, used in assessing fetal well-being but not specifically indicative of neural tube defects. Option D, inhibin, is a hormone produced by the ovaries and placenta and is not used in prenatal screening for neural tube defects.
Educationally, understanding the rationale behind prenatal screening tests is vital for nursing students and healthcare professionals working in maternal and pediatric care. Recognizing the significance of specific markers like AFP in detecting fetal anomalies empowers healthcare providers to offer informed care and support to pregnant women and their babies. This knowledge contributes to improved prenatal care and outcomes for both mother and child.
Option A, human chorionic gonadotropin (hCG), is a hormone produced during pregnancy but is not specifically associated with neural tube defects. Estriol (Option C) is a hormone produced by the placenta and fetal liver, used in assessing fetal well-being but not specifically indicative of neural tube defects. Option D, inhibin, is a hormone produced by the ovaries and placenta and is not used in prenatal screening for neural tube defects.
Educationally, understanding the rationale behind prenatal screening tests is vital for nursing students and healthcare professionals working in maternal and pediatric care. Recognizing the significance of specific markers like AFP in detecting fetal anomalies empowers healthcare providers to offer informed care and support to pregnant women and their babies. This knowledge contributes to improved prenatal care and outcomes for both mother and child.